Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/21/2014WO2013121452A8 Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease
08/21/2014US20140236069 Pharmacokinetics of iontophoretic sumatriptan administration
08/21/2014US20140235864 Biphenyl derivatives
08/21/2014US20140235835 Calicheamicin derivative-carrier conjugates
08/21/2014US20140235799 Method for preparation of a controlled release system
08/21/2014US20140235730 Solid, edible, chewable laxative composition
08/21/2014US20140235729 Benzylamine containing compositions and methods for appetite suppression
08/21/2014US20140235726 Method of improving cognition and increasing dendritic complexity in humans with down syndrome and compositions therefor
08/21/2014US20140235725 Preconfigured gel with infused drug for ultrasound
08/21/2014US20140235722 Organic Compounds
08/21/2014US20140235721 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/21/2014US20140235720 Treating patients with intravenous ibuprofen
08/21/2014US20140235719 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
08/21/2014US20140235717 Food products, preparation, and therapeutic methods
08/21/2014US20140235716 Stable pharmaceutical composition and methods of using same
08/21/2014US20140235714 Cancer therapy
08/21/2014US20140235713 Method of treating lysosomal storage disorders
08/21/2014US20140235712 Conformable coating and composition
08/21/2014US20140235711 Delayed release, oral dosage compositions that contain amorphous cddo-me
08/21/2014US20140235710 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
08/21/2014US20140235709 Orally dispersible tablet
08/21/2014US20140235708 Pharmaceutical composition on the basis of nanomicelles containing epigallocatechin gallate and a method of administration thereof to treat atopic dermatitis, crohn's disease, adenomyosis, and hyperplastic diseases of the prostate gland
08/21/2014US20140235707 Methods and compositions for predicting response to eribulin
08/21/2014US20140235706 Cancer cell targeting using nanoparticles
08/21/2014US20140235705 Formulations of thiophene compounds
08/21/2014US20140235704 Thiophene compounds
08/21/2014US20140235702 Small molecule inhibitors of mcl-1 and the uses of thereof
08/21/2014US20140235692 Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for preventing and/or treating cardiotoxic effects caused by chemotherapy and/or radiation
08/21/2014US20140235691 Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection
08/21/2014US20140235690 Ischemia/reperfusion protection compositions and methods of using
08/21/2014US20140235688 Treatment of external parasites by oral administration of parasiticidal agents
08/21/2014US20140235687 Methods of treating cognitive dysfunction by modulating brain energy metabolism
08/21/2014US20140235686 ZNF365/ZFP365 Biomarker Predictive of Anti-Cancer Response
08/21/2014US20140235685 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases
08/21/2014US20140235684 Metal-salen complex compound responsive drug and intra-corporeal behavior control system for metal-salen complex compound
08/21/2014US20140235683 Compositions and Methods for the Treatment of Norovirus Infection
08/21/2014US20140235681 Combination therapy for glaucoma
08/21/2014US20140235678 Topical Ophthalmological Pharmaceutical Composition containing Sorafenib
08/21/2014US20140235676 Rxr agonist compounds and methods
08/21/2014US20140235675 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
08/21/2014US20140235674 Method of treating thermoregulatory disfunction with paroxetine
08/21/2014US20140235671 Scriptaid isosteres and their use in therapy
08/21/2014US20140235670 Treatment of progressive forms of multiple sclerosis with laquinimod
08/21/2014US20140235667 Imidazopyridyl compounds as aldosterone synthase inhibitors
08/21/2014US20140235665 Anti-constipation composition
08/21/2014US20140235664 Stable pharmaceutical formulations of methylnaltrexone
08/21/2014US20140235663 Buprenorphine for the treatment of acute suicidality
08/21/2014US20140235662 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
08/21/2014US20140235660 Compounds and compositions as selective estrogen receptor degraders
08/21/2014US20140235659 Delta-tocotrienol treatment and prevention of pancreatic cancer
08/21/2014US20140235658 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/21/2014US20140235656 Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
08/21/2014US20140235651 Pharmaceutical composition
08/21/2014US20140235650 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
08/21/2014US20140235649 Use of phosphatase inhibitors or histone deacetylase inhibitors to treat diseases characterized by loss of protein function
08/21/2014US20140235648 Liquid preparation comprising pimobendan
08/21/2014US20140235646 Methods and Compositions for the Treatment of Body Weight Related Disorders
08/21/2014US20140235644 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
08/21/2014US20140235638 Anti-Infective Agents and Uses Thereof
08/21/2014US20140235631 Efflux inhibitor compositions and methods of treatment using the same
08/21/2014US20140235630 Compositions and methods for the treatment of proliferative diseases
08/21/2014US20140235627 ß2-ADRENOCEPTOR AGONIST FOR IMPROVEMENT OF EXERCISE TOLERANCE
08/21/2014US20140235625 Modulators of cystic fibrosis transmembrane conductance regulator
08/21/2014US20140235621 Hematopoietic neoplasm chemotherapy
08/21/2014US20140235620 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
08/21/2014US20140235619 Agents and methods for treating ischemic and other diseases
08/21/2014US20140235618 Methods for treatment of atopic dermatitis and inflammatory skin disorders
08/21/2014US20140235617 Combinations of Hepatitis C Virus Inhibitors
08/21/2014US20140235616 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
08/21/2014US20140235610 Use of s1p receptor modulator
08/21/2014US20140235609 Carbamate/urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
08/21/2014US20140235607 Compositions and methods for treating and preventing coronary heart disease
08/21/2014US20140235606 Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide
08/21/2014US20140235605 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
08/21/2014US20140235603 Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
08/21/2014US20140235602 Compositions and Methods for Suppressing Endometrial Proliferation
08/21/2014US20140235601 Use of Aromatase Inhibitor Or Estrogen Blocker For Increasing Spermatogenesis Or Testosterone Levels In Males
08/21/2014US20140235599 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
08/21/2014US20140235598 Tablet containing dehydroepiandrosterone (dhea)
08/21/2014US20140235597 Ophthalmologic Irrigation Solutions and Method
08/21/2014US20140235596 Fat composition
08/21/2014US20140235595 Cocrystals of progesterone
08/21/2014US20140235594 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
08/21/2014US20140235593 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
08/21/2014US20140235590 Pharmaceutical compounds for use in the therapy of clostridium difficile infection
08/21/2014US20140235582 Hiv replication inhibitors
08/21/2014US20140235578 Methods for treating neoplasia and for identifying compositions useful in such therapy
08/21/2014US20140235577 External skin agent comprising modified clay for preventing inflammation
08/21/2014US20140235574 Aripiprazole complex formulation and method
08/21/2014US20140235572 Agent for preventing or treating htlv-i associated myelopathy
08/21/2014US20140235571 Method for treatment of pulmonary fibrosis
08/21/2014US20140235570 Therapeutic composition for the treatment of perianal disorders
08/21/2014US20140235569 Composition and methods for the production of s-adenosylmethionine within the body
08/21/2014US20140235567 5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
08/21/2014US20140235566 Pyrimidine nucleosides and their monophosphate prodrugs for treatment of viral infections and cancer
08/21/2014US20140235564 Methods for treating neural cell swelling
08/21/2014US20140235563 2',4'-substituted nucleosides as antiviral agents
08/21/2014US20140235562 Compounds and methods of treating ocular disorders
08/21/2014US20140235560 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
08/21/2014US20140235559 Anti-cancer pharmaceutical composition
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 7860